Procaspase-2S inhibits procaspase-3 processing and activation, preventing ROCK-1-mediated apoptotic blebbing and body formation in human B lymphoma Namalwa cells

Apoptosis

Volumn 10, Issue 2, 2005, Pages 313-322

  Parent, N ^a   Sane A T ^a   Droin, N ^a,c   Bertrand, R ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Apoptosis; Caspase; ROCK 1; VP 16

Indexed keywords

CASPASE; ETOPOSIDE; PROCASPASE 2L; PROCASPASE 2S; PROCASPASE 3; PROCASPASE 9; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME BINDING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOMA; PRIORITY JOURNAL;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 2; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL MEMBRANE; CELL-FREE SYSTEM; DNA; DNA FRAGMENTATION; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL; MONOCYTES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION; U937 CELLS;

EID: 18144387219     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-0805-7     Document Type: Article

References (67)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
2. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res 1989; 49: 5870-5878.
3. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2353-2362.
4. Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 1991; 51: 6280-6285.
5. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
6. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
7. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
8. Cryns V, Yuan JY, Proteases to die for. Genes Dev 1998; 12: 1551-1570.
9. Salvesen GS, Dixit VM. Caspase activation: The induced-proximity model. Proc Natl Acad Sci USA 1999; 96: 10964-10967.
10. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 1028-1042.
11. Schmitt E, Sane AT, Bertrand R. Activation and role of caspases in chemotherapy-induced apoptosis. Drug Resist Updates 1999; 2: 21-29.
12. Earnshaw WC, Martin LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
13. Zhang JD, Reedy MC, Hannun YA, Obeid LM. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J Cell Biol 1999; 145: 99-108.
14. Cotter TG, Lennon SV, Glynn JM, Green DR. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992; 52: 997-1005.
15. Suarez-Huerta N, Mosselmans R, Dumont JE, Robaye B. Actin depolymerization and polymerization are required during apoptosis in endothelial cells. J Cell Physiol 2000; 184: 239-245.
16. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001; 3: 339-345.
17. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001; 3: 346-352.
18. Coleman ML, Olson MF. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 2002; 9: 493-504.
19. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of Pak2. Science 1997; 276: 1571-1574.
20. Droin N, Rebe C, Bichat F, Hammann A, Bertrand R, Solary E. Modulation of apoptosis by procaspase-2 short isoform: Selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization. Oncogene 2001; 20: 260-269.
21. Schmitt E, Cimoli G, Steyaert A, Bertrand R. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp Cell Res 1998; 240: 107-121.
22. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144: 281-292.
23. Droin N, Beauchemin M, Solary E, Bertrand R. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade. Cancer Res 2000; 60: 7039-7047.
24. Schmitt E, Paquet C, Beauchemin M, Bertrand R. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase 9 activation. Oncogene 2004; 23: 3915-3931.
25. Schmitt E, Steyaert A, Cimoli G, Bertrand R. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Cell Death Differ 1998; 5: 506-516.
26. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
27. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
28. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470.
29. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739-750.
30. Krajewska M, HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997; 57: 1605-1613.
31. Droin N, Dubrez L, Eymin B, et al. Upregulation of Casp genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene 1998; 16: 2885-2894.
32. Logette E, Wotawa A, Solier S, Desoche L, Solary E, Carcos L. The human caspase-2 gene: Alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression. Oncogene 2003; 22: 935-946.
33. Soller S, Lansiaux A, Logette E, et al. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol Cancer Res 2004; 2: 53-61.
34. Martins LM, Kottke TJ, Kaufmann SH, Earnshaw WC. Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis. Blood 1998; 92: 3042-3049.
35. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-1321.
36. Mannick JB, Schonhoff C, Papeta N, et al. S-Nitrosylation of mitochondrial caspases. J Cell Biol 2001; 154: 1111-1116.
37. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 2000; 275: 26661-26664.
38. Suzuki Y, Nakabayashi Y, Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 2001; 98: 8662-8667.
39. Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor: A novel function for a caspase prodomain. J Biol Chem 1998; 273: 24535-24542.
40. Mancini M, Nicholson DW, Roy S, et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998; 140: 1485-1495.
41. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-393.
42. Mancini M, Machamer CE, Roy S, et al. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 2000; 149: 603-612.
43. Ito A, Uehara T, Nomura Y. Isolation of Ich-1S (caspase-2S)-binding protein that partially inhibits caspase activity. FEBS Lett 2000; 470: 360-364.
44. Daniels H, Bokoch G. p21-activated protein kinase: A crucial component of morphological signaling? Trends Biochem Sci 1999; 24: 350-355.
45. Leverrier Y, Ridley AJ. Apoptosis: Caspases orchestrate the ROCK 'n' bleb. Nat Cell Biol 2001; 3: E91-E92.
46. Sanders LC, Matsumura F, Bokoch GM, De Lanerolle P. Inhibition of myosin light chain kinase by p21 activated kinase. Science 1999; 283: 2083-2085.
47. Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, Wysolmerski RB. Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 2000; 275: 18366-18374.
48. Porter A, Janicke R. Emerging roles of caspase-3 in apoptosis. Cell Death Diff 1999; 6: 99-104.
49. Liu XS, Zou H, Slaughter C, Wang XD. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175-184.
50. Liu XS, Li P, Widlak P, et al. The 40-Kda subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 1998; 95: 8461-8466.
51. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
52. Bruno S, DelBino G, Lassota P, Giaretti W, Darynkiewicz Z. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL60 leukemic cells and normal thymocytes. Leukemia 1992; 6: 1113-1120.
53. Weaver VM, Lach B, Walker PR, Sikorska M. Role of proteolysis in apoptosis: Involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochem Cell Biol 1993; 71: 488-500.
54. Yoshida A, Takauji R, Inuzuka M, Ueda T, Nakamura T. Role of serine and Ice-like proteases in induction of apoptosis by etoposide in human leukemia Hl-60 cells. Leukemia 1996; 10: 821-824.
55. Hara SS, Halicka HD, Bruno S, Gong JP, Traganos F, Darzynkiewicz Z. Effect of protease inhibitors on early events of apoptosis. Exp Cell Res 1996; 223: 372-384.
56. Ghibelli L, Maresca V, Coppola S, Gualandi G. Protease inhibitors block apoptosis at intermediate stages: A compared analysis of DNA fragmentation and apoptotic nuclear morphology. FEBS Lett 1995; 377: 9-14.
57. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y. Bcl-2 expression prevents activation of the Ice protease cascade. Oncogene 1996; 12: 2251-2257.
58. Sané AT, Bertrand R. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res 1998; 58: 3066-3072.
59. Wright SC, Wei QS, Zhong J, Zheng H, Kinder DH, Larrick JW. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med 1994; 180: 2113-2123.
60. Torriglia A, Perani P, Brossas JY, et al. L-Dnase II, a molecule that links proteases and endonucleases in apoptosis, derives from the ubiquitous serpin leukocyte elastase inhibitor. Mol Cell Biol 1998; 18: 3612-3619.
61. 2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis. Cancer Res 1998; 58: 2576-2582.
62. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412: 95-99.
63. Duan H, Dixit VM. Raidd is a new death adaptor molecule. Nature 1997; 385: 86-89.
64. Ahmad M, Srinivasula SM, Wang LJ, et al. Cradd, a novel human apoptotic adaptor molecule for caspase-2, and Fas/Tumor necrosis factor receptor-interacting protein Rip. Cancer Res 1997 57: 615-619.
65. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002; 297: 1352-1354.
66. Read SH, Baliga BC, Ekert PG, Vaux DL, Kumar S. A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 2002; 159: 739-745.
67. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846.